2021-04-02
In a recent document from the Bank of Japan, the central bank stressed the need for offline availability.
The Bank for International Settlements (BIS), in collaboration with a group of seven central banks, published its first joint report into central bank digital currencies on Oct. 9, focusing on the foundational principles and core features of CBDCs.
Alongside the report, the Bank of Japan, one of the members of the group, released a document outlining its own specific approach to CBDCs from a Japan-centric perspective.
According to the BoJ report, it will begin the first of several testing phases for its own CBDC sometime in 2021. This will include the development of a test environment for the currency and experiments on its basement functions as a payment instrument.
The BoJ report notes that a core feature of the digital currency must be resilience in the face of infrastructure disrupted by forces Majeure, stating:
"Offline use in times of system and network failures as well as electrical outages is also important for Japan, given the frequent occurrence of natural disasters."
Due to the nature of its geography, Japan is prone to a wide range of natural disasters, including earthquakes, tsunamis, floods, typhoons, cyclones and volcanic eruptions.
The report gives no details on how providing against such events might be achieved, although there are solutions that address potential electrical or network failures for Bitcoin (BTC) and other blockchain-based cryptocurrencies.
These include the development of mesh networks based around long-wave radio transmitters, and Blockstream's satellite network, which broadcasts Bitcoin transactions via space.
The BIS digital currency research group was announced in January 2020, and included central banks from Japan, Canada, the United Kingdom, Sweden, Switzerland and the European Central Bank. The United Stated Federal Reserve has also since joined the group.
Light Vision 2024 Shenzhen International Optics Fair
CFHEC Hosts the 19th China-Ethiopia Friendship Relay Race and Celebrates Its 20th Anniversary
Innovation of traditional Chinese medicine-- Tianjiang Extract Granules
The second series of the World Chinese Medicine Forum in 2024 was held successfully.
Tianjiang Pharmaceutical, a subsidiary of China Traditional Chinese Medicine Holdings, Participated in the Jiangsu International Service Trade Exhibition in Kuala Lumpur, Malaysia
Tianjiang Pharmaceutical and China-Brazil Traditional Chinese Medicine International Cooperation Base Jointly Host Series of Traditional Chinese Medicine Academic lectures
©copyright 2009-2020 Singapore Info Map